comparemela.com

Latest Breaking News On - Mayer professor - Page 2 : comparemela.com

Experts' Perspectives: Top Story in Nephrology for 2023

At ASN Kidney Week 2023, we collected perspectives from 10 key opinion leaders in nephrology on what they see as the most significant news in their specialty from the past year.

Canada
Colorado
United-states
Philadelphia
Pennsylvania
Monaco
American
Oliver-gross
Richard-johnson
Rajiv-agarwal
Michelle-rheault
Amit-garg

Examining eGFR Slopes and Changes in Proteinuria in IgA Nephropathy, with Jonathan Barratt, MD

Joanthan Barratt, MD, discusses the results of a RaDaR analysis aimed at examining trends in time-averaged proteinuria and eGFR slope in patients with IgA nephropathy.

United-states
United-kingdom
Leicester
American
Jonathan-barratt
American-society-of-nephrology-kidney-week
Alnylam-pharmaceuticals
Novartis
United-kingdom-kidney-association
University-of-leicester
American-society
Nephrology-kidney-week

Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis

Budesonide Reduces eGFR Decline, Effect Could Prevent Clinical Events in IgA Nephropathy

Data for a pair of studies presented at Kidney Week 2023 provide an overview of the effects of eGFR and how this might translate to potential long-term benefit in patients IgA nephropathy.

United-states
American
Richard-lafayette
Jonathan-barratt
University-of-leicester
Stanford-glomerular-disease-center
Alnylam-pharmaceuticals
American-society-of-nephrology-kidney-week
Novartis
American-society
Nephrology-kidney-week
Igard-study

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023

Alpine Immune Sciences Presents Initial Clinical Data on Povetacicept in Autoimmune Glomerulonephritis in a Late-Breaking Poster Session at the American Society of Nephrology Kidney Week 2023
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Philadelphia
Pennsylvania
United-states
American
Jonathan-barratt
James-tumlin
Alpine-immune-sciences-inc
University-of-leicester
Nephronet-clinical-trials-consortium
Alpine-immune-sciences
Exchange-commission
Nasdaq
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.